1. Allegra JC, Sholar PW, Drake JC, Bagley C, Lippman ME, Chabner BA (1986) A phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil (5-FU) and leucovorin. Proceedings, Symposium on the Development of Folates and Folic Acid Antagonists in Cancer Chemotherapy, Innisbrook Tarpon Springs, January 23?26, 1986, p 5
2. Allegra CJ, Egan GF, Drake JC, et al (1988) The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. In: Rustum Y, McGuire J (eds) The expanding role of folates and fluoropyrimidines in cancer chemotherapy. Plenum, New York, pp 107?110
3. Beretta G, Locatelli C, Tabiadon D, et al (1987) Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen. Oncology 44: 6?12
4. Brambilla C, Rossi A, Bonfante V, et al (1986) Phase II study of doxorubicin versus epirubicin in advanced breast cancer. Cancer Treat Rep 70: 261?266
5. Doroshow TH, Bertrand M, Multhauf P, et al (1987) Prospective randomized trial comparing 5-FU versus 5-FU and high dose folinic acid (HDFA for treatment of advanced colorectal cancer (abstract). Proc Am Soc Clin Oncol 6: 96